The Missouri Court of Appeals reversed a jury's decision that awarded $72 million to a plaintiff who claimed Johnson & Johnson's talcum powder products caused her ovarian cancer. But the court's ruling was based on a jurisdictional issue, not the lack of scientific evidence underpinning her claim.
